Dow Jones

40,589.34

1.64%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Bone Biologics Corporation (BBLG)
Bone Biologics Corporation (BBLG) Noticias

BBLG

Bone Biologics (BBLG)

Bone Biologics Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BBLG

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/06/2024	07:35	GlobeNewswire Inc.	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing	NASDAQ:BBLG	Bone Biologics Corporation
06/03/2024	15:15	Business Wire	Bone Biologics Announces Closing of $2.0 Million Public Offering	NASDAQ:BBLG	Bone Biologics Corporation
04/03/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BBLG	Bone Biologics Corporation
04/03/2024	16:21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:BBLG	Bone Biologics Corporation
04/03/2024	08:15	Business Wire	Bone Biologics Announces Pricing of $2.0 Million Public Offering	NASDAQ:BBLG	Bone Biologics Corporation
01/03/2024	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
01/03/2024	07:00	Business Wire	Bone Biologics Reports Progress With NB1 Clinical Program	NASDAQ:BBLG	Bone Biologics Corporation
26/02/2024	15:50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
21/02/2024	16:05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BBLG	Bone Biologics Corporation
14/02/2024	17:41	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
30/01/2024	16:09	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BBLG	Bone Biologics Corporation
19/01/2024	16:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
17/01/2024	16:21	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
11/01/2024	07:00	Business Wire	Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors	NASDAQ:BBLG	Bone Biologics Corporation
10/01/2024	16:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
10/01/2024	07:00	Business Wire	Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements	NASDAQ:BBLG	Bone Biologics Corporation
05/01/2024	16:15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BBLG	Bone Biologics Corporation
18/12/2023	07:00	Business Wire	Bone Biologics Announces 1-for-8 Reverse Stock Split	NASDAQ:BBLG	Bone Biologics Corporation
29/11/2023	11:26	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BBLG	Bone Biologics Corporation
27/11/2023	05:10	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BBLG	Bone Biologics Corporation
20/11/2023	11:38	Business Wire	Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BBLG	Bone Biologics Corporation
20/11/2023	06:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BBLG	Bone Biologics Corporation
20/11/2023	06:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BBLG	Bone Biologics Corporation
20/11/2023	05:50	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
16/11/2023	15:43	Business Wire	Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BBLG	Bone Biologics Corporation
14/11/2023	15:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BBLG	Bone Biologics Corporation
09/11/2023	15:51	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BBLG	Bone Biologics Corporation
26/09/2023	07:00	Business Wire	Bone Biologics Provides Scientific Update on NB1 Bone Graft Device	NASDAQ:BBLG	Bone Biologics Corporation
15/09/2023	15:48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BBLG	Bone Biologics Corporation
03/08/2023	05:25	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:BBLG	Bone Biologics Corporation